Madhavi Sahadevan | Pharmaceutical Science | Women Researcher Award

Published on by Academic Achievements

Women Researcher Award

Madhavi Sahadevan
Thiru Vi Ka Government Arts College

Madhavi Sahadevan
Affiliation Thiru Vi Ka Government Arts College
Country India
Scopus ID 58563556500
Documents 4
Citations 8
h-index 2
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards

Madhavi Sahadevan is a researcher affiliated with Thiru Vi Ka Government Arts College, India, whose scholarly work falls within pharmacology, toxicology and pharmaceutical science. Her publication record is indexed in Scopus under author identifier 58563556500 [1]. She is presented here in connection with the Women Researcher Award at the International Academic Achievements & Awards event [2].

Abstract

This article presents a neutral overview of the scholarly profile of Madhavi Sahadevan, a researcher at Thiru Vi Ka Government Arts College working in pharmacology, toxicology and pharmaceutical science. According to Scopus, her profile lists four documents, eight citations and an h-index of two [1]. The article summarizes her research profile, contributions, bibliometric standing and relevance to the Women Researcher Award [2].

Keywords

Women researcher; pharmacology; toxicology; pharmaceutical science; Scopus; research recognition; academic achievement.

Introduction

Academic recognition programs seek to acknowledge researchers whose work contributes to scientific knowledge and to the visibility of women in research. The Women Researcher Award, presented within the International Academic Achievements & Awards event, is intended to highlight such contributions across disciplines [2]. Madhavi Sahadevan is associated with Thiru Vi Ka Government Arts College in India, a public institution of higher education. Her research activity is documented through the Scopus database, which provides a verifiable record of indexed output [1].

Research Profile

Madhavi Sahadevan’s indexed work is classified under pharmacology, toxicology and pharmaceutical science, a field concerned with the actions of drugs, the safety of chemical substances and the development of therapeutic formulations. Her Scopus record is identified by author ID 58563556500 and currently lists four documents [1].

  • Affiliation: Thiru Vi Ka Government Arts College, India
  • Primary subject area: Pharmacology, Toxicology and Pharmaceutical Science
  • Scopus identifier: 58563556500

Research Contributions

The research contributions of Madhavi Sahadevan are reflected in peer-reviewed publications indexed by Scopus. Work in pharmacology and pharmaceutical science typically advances understanding of bioactive compounds, their mechanisms and their safety profiles. Her publications add to this body of literature and are accessible through the DOI system, which allows readers to consult the original articles directly [3]. Readers are encouraged to consult the primary publications for specific methods and findings [1].

Publications

Scopus lists four documents attributed to Madhavi Sahadevan [1]. The complete and current bibliography, including titles, journals and publication years, is available through her Scopus author profile. Individual articles can be located and cited through their DOIs [3].

Research Impact

Bibliometric indicators offer a limited but useful view of scholarly reach. As recorded in Scopus, Madhavi Sahadevan’s work has received eight citations, and her h-index is two [1]. These figures indicate an early-career or developing research record, and they may change as new publications appear and existing work is cited.

  • Documents: 4
  • Citations: 8
  • h-index: 2

Award Suitability

The Women Researcher Award recognizes women who contribute to research through indexed publications and scholarly engagement [2]. Madhavi Sahadevan’s verifiable Scopus record, her focus on pharmacology, toxicology and pharmaceutical science, and her affiliation with a government arts college provide a documented basis for consideration [1]. Final selection rests with the organizing committee and its stated criteria.

Conclusion

Madhavi Sahadevan is a researcher at Thiru Vi Ka Government Arts College whose indexed work in pharmacology, toxicology and pharmaceutical science is documented in Scopus. With four documents, eight citations and an h-index of two, her record reflects a growing contribution to the field [1]. Her association with the Women Researcher Award highlights the importance of recognizing women in research [2].

References

  1. Elsevier. (n.d.). Scopus author details: Madhavi Sahadevan, Author ID 58563556500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58563556500
  2. Quantum mechanical approaches and molecular docking studies of metal based anticancer drugs cis-Diammine glycolato platinum and Diaminocyclohexane oxalatoplatinum structures.
    https://www.sciencedirect.com/science/article/abs/pii/S1476927123001317
  3. Molecular Docking Studies of Platinum Metal-Based Anticancer Drugs Cis-Diamineglycolatoplatinum and its Derivatives Binding Affinity with Three Different Types of Cancer Cell.
    https://nanobioletters.com/wp-content/uploads/2024/09/LIANBS141.036.pdf
  4. ORCID. (n.d.). ORCID: Connecting research and researchers. ORCID, Inc.
    https://orcid.org/
  5. Elsevier. (n.d.). Scopus: Abstract and citation database. Elsevier B.V.
    https://www.scopus.com/

Neeraj Thakur | Pharmacology | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Neeraj Thakur
Affiliation University of Oklahoma Health Campus
Country United States
Scopus ID 56645996700
Documents 37
Citations 1,149
h-index 20
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards
ORCID 0000-0003-1758-0737

Neeraj Thakur
University of Oklahoma Health Campus, United States

The Innovative Research Award recognizes sustained scholarly excellence, impactful scientific contributions, and innovation in biomedical and pharmaceutical sciences. Neeraj Thakur has established an active research profile focused on advanced drug delivery systems, nanomedicine, pharmaceutical formulations, biomaterials, and translational therapeutic technologies. His published work demonstrates interdisciplinary collaboration across pharmaceutical science, toxicology, and biomedical engineering while contributing to improved therapeutic delivery strategies for dermatological and ocular applications.[1]

Abstract

Neeraj Thakur’s research integrates pharmaceutical sciences, nanotechnology, biomaterials, and targeted therapeutic delivery to address challenges associated with drug stability, controlled release, tissue targeting, and improved clinical efficacy. His work encompasses hybrid micellar systems, ocular nanoformulations, RNA interference technologies, and advanced pharmaceutical carriers designed to improve patient outcomes through innovative formulation strategies.[2]

Keywords

Drug Delivery Systems, Nanomedicine, Hybrid Micelles, RNA Interference, Corneal Therapeutics, Pharmaceutical Sciences, Targeted Drug Delivery

Introduction

Modern pharmaceutical research increasingly focuses on precision drug delivery, sustained therapeutic release, and biomaterial-enabled treatment strategies. Neeraj Thakur’s research aligns with these objectives through the development of multifunctional nanocarriers and advanced pharmaceutical formulations capable of enhancing therapeutic performance while minimizing adverse effects. His publications demonstrate an interdisciplinary approach combining pharmaceutical sciences with materials engineering and translational medicine.[3]

Research Profile

  • Scopus Author ID: 56645996700
  • 37 indexed scholarly publications.
  • 1,149 citations reflecting broad scientific visibility.
  • h-index of 20 demonstrating consistent research influence.
  • Research spans pharmacology, toxicology, pharmaceutical sciences, nanomedicine and biomaterials.

Research Contributions

The research contributions of Neeraj Thakur include the design of crosslinked hybrid micellar systems for cutaneous drug delivery, sustained nanoformulations for corneal wound healing, and RNA interference applications in viral diagnostics and therapeutics. These investigations emphasize formulation optimization, targeted delivery, therapeutic efficiency, and translational biomedical applications while supporting the broader advancement of pharmaceutical technology.[4]

Publications

  • Crosslinked hybrid micellar platform for targeted cutaneous drug delivery
    Colloids and Surfaces B: Biointerfaces (2026). DOI: 10.1016/j.colsurfb.2026.115998
  • Crosslinked Hybrid Micellar Platform for Targeted Cutaneous Drug Delivery
    Preprint (2026). DOI: 10.2139/ssrn.6250431
  • A multimodal approach to smart and sustained drug delivery for corneal wound management: the GelPol nanoformulation
    Nanomedicine (2025). DOI: 10.1080/17435889.2025.2550236
  • RNAi in viral control and diagnostics
    Book Chapter (2025). DOI: 10.1088/978-0-7503-4987-1ch12

Research Impact

The documented citation profile, publication record, and interdisciplinary research portfolio indicate sustained academic influence within pharmaceutical sciences. Contributions toward targeted drug delivery technologies and nanomedicine support ongoing developments in precision therapeutics, controlled release formulations, and biomedical innovation. The citation metrics further demonstrate recognition by the international research community.[1]

Award Suitability

Based on the available scholarly metrics, publication output, interdisciplinary research contributions, and demonstrated impact within pharmaceutical sciences, Neeraj Thakur represents a suitable candidate for recognition through the Innovative Research Award. His research portfolio reflects innovation in drug delivery technologies, sustained scientific productivity, and contributions supporting future translational healthcare solutions.[2]

Conclusion

Neeraj Thakur has established a notable research profile characterized by innovation in pharmaceutical formulation science, targeted therapeutic delivery, nanotechnology, and biomaterial-based treatment strategies. Supported by strong bibliometric indicators and peer-reviewed scholarly publications, his work contributes to the continued advancement of pharmaceutical sciences and biomedical research while reflecting the qualities recognized by the Innovative Research Award.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Neeraj Thakur, Author ID 56645996700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56645996700
  2. Thakur, N. (2026). Crosslinked hybrid micellar platform for targeted cutaneous drug delivery. Colloids and Surfaces B: Biointerfaces.
    https://doi.org/10.1016/j.colsurfb.2026.115998
  3. Thakur, N. (2026). Crosslinked Hybrid Micellar Platform for Targeted Cutaneous Drug Delivery. SSRN Preprint. https://doi.org/10.2139/ssrn.6250431
  4. Thakur, N. (2025). A multimodal approach to smart and sustained drug delivery for corneal wound management: the GelPol nanoformulation. Nanomedicine. https://doi.org/10.1080/17435889.2025.2550236
  5. Thakur, N. (2025). RNAi in viral control and diagnostics. Viral Diseases: History and New Developments in Diagnostics and Therapeutics.
    https://doi.org/10.1088/978-0-7503-4987-1ch12